This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Charité – Universitätsmedizin Berlin, Max-Delbrueck-Centrum Fuer Molekulare Medizin, Max-Delbruck-Centrum Fur Molekular Medizin. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 283 
2 out of 18 
1 out of 1 Years Active: 2016-2019
Title: Ingolf Schimke: Innovator in Autoimmune Disease Therapy
Introduction
Ingolf Schimke is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of aptamers for therapeutic and diagnostic purposes. With a total of three patents to his name, Schimke's work focuses on addressing various autoimmune diseases.
Latest Patents
Schimke's latest patents include innovative uses of aptamers in the therapy and diagnosis of autoimmune diseases. One of his inventions is directed towards an aptamer comprising specific nucleic acid sequences for use in treating conditions such as cardiomyopathy, dilated cardiomyopathy, and Alzheimer's disease, among others. This groundbreaking work aims to improve therapeutic outcomes for patients suffering from these complex diseases.
Career Highlights
Throughout his career, Ingolf Schimke has worked with esteemed institutions such as the Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin. His experience in these prominent research centers has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Schimke has collaborated with notable colleagues, including Annekathrin Haberland and Gerd Wallukat. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in the field of autoimmune disease research.
Conclusion
Ingolf Schimke's contributions to the field of biotechnology, particularly in the development of aptamers for autoimmune diseases, highlight his role as a leading inventor. His work continues to pave the way for advancements in therapeutic and diagnostic applications, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile